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Abstract
Background: Prevalence of cardiovascular disease (CVD) in women shows regional variations not explained by
common risk factors. Analysis of CVD incidence will provide insight into whether there is further divergence
between regions with increasing age.
Methods: Seven-year follow-up data on 2685 women aged 59-80 (mean 69) at baseline from 23 towns in the UK
were available from the British Women’s Heart and Health Study. Time to fatal or non-fatal CVD was analyzed using
Cox regression with adjustment for risk factors, using multiple imputation for missing values.
Results: Compared to South England, CVD incidence is similar in North England (HR 1.05 (95% CI 0.84, 1.31)) and
Scotland (0.93 (0.68, 1.27)), but lower in Midlands/Wales (0.85 (0.64, 1.12)). Event severity influenced regional
variation, with South England showing lower fatal incident CVD than other regions, but higher non-fatal incident
CVD. Kaplan-Meier plots suggested that regional divergence in CVD occurred before baseline (before mean
baseline age of 69).
Conclusions: In women, regional differences in CVD early in adult life do not further diverge in later life. This may
be due to regional differences in early detection, survivorship of women entering the study, or event severity.
Targeting health care resources for CVD by geographic variation may not be appropriate for older age-groups.
Background
Geographical variations in coronary heart disease (CHD)
and stroke (together termed cardiovascular disease
(CVD) here) have been identified and reported for a
range of countries in terms of both prevalence [1-16]
and incidence [17-21]. Furthermore, a number of studies
have investigated the relationship between geographical
variation in these outcomes and known risk factors
[11,17,18,22-24]. The British Regional Heart Study
(BRHS) reported that the north-south differences in
CVD incidence in men could largely be explained by
classical risk factors (smoking, physical activity, body
mass index (BMI), alcohol consumption, systolic blood
pressure, serum total cholesterol, occupational social
class, and height) [18]. In women, differences in CVD
prevalence across four broad regions of the UK (Scot-
land, North England, Midlands/Wales, and South Eng-
land) were reported at the baseline survey of the British
Women’s Heart and Health Study (BWHHS) [11]. The
highest prevalence of CVD was observed in Scotland,
and the lowest in South England. In contrast to findings
in men drawn from the same geographic areas, this var-
iation by region remained after adjustment for known
risk factors (age, systolic blood pressure, diastolic blood
pressure, total cholesterol, high density lipoprotein cho-
lesterol (HDLc), smoking physical activity, fruit con-
sumption, social class, and use of aspirin/statins). The
work presented here extends this to consider geographi-
cal variations in the incidence of CVD in women in the
BWHHS, using data from seven years of follow-up of
the cohort.
Methods
Methods for the BWHHS have been published pre-
viously [11], and were based on the BRHS for men [25].
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In summary, one GP practice in each of 23 towns in the
UK was selected for the study, matching those towns in
the BRHS. Women registered at these practices were
invited to complete a baseline questionnaire about
health and lifestyle (Additional file 1), and to attend a
clinical examination to obtain measurements and blood
samples. Details on diagnosed CVD, treatments and risk
factors were obtained through nurse-led interview. Of
the 7296 women invited between April 1999 and March
2001, 4286 (59%) responded at baseline. A further two
questionnaires have since been completed, in 2003
(three-year follow-up; Additional files 2, 3) and 2007
(seven-year follow-up; Additional file 4), with 3677 (86%
of baseline responders, 89% of those still alive) and 2685
(63% of baseline responders, 71% of those still alive)
responding respectively. Figure 1 shows the flow of the
participants through the study. GP practice records were
reviewed in tandem with the questionnaires, and all
women are flagged with the UK National Health Service
Central Register, which provides mortality data via the
Office of National Statistics.
Multi-centre (London Multi-centre Regional Ethics
Committee) and local research ethics committees pro-
vided approval for the study and informed consent was
obtained from the women to complete the measure-
ments used in this study, abstract information from
medical records, link to the National Health Service
Central Register and store data.
Outcomes
Cardiovascular disease (CVD) was defined as any of
angina, unstable angina, myocardial infarction or stroke.
Prevalent events were informed by either self-report at
baseline or medical record review events dated prior to
baseline. Incident events were informed by either self-
report at the three- or seven-year follow-up, medical
record review, or death certificate, using a cut-off of
30th September 2007 for all sources. CVD deaths were
indicated by ICD10 codes I200-259, I516, I600-679,
I690-699, G460-469, and G450-3 (underlying or other-
wise). Self-reported strokes were only included where
symptoms were >24 hours (to exclude potential cases of
transient ischaemic attack (TIA) mis-reported as stroke).
For potential events identified by review of medical
records, a number of criteria were applied in order to
count an event as incident CVD for analysis. In doubtful
cases a telephone discussion was held with the woman’s
general practitioner to confirm or reject CVD diagnoses.
For MI, at least one of the following was required: (1)
ECG evidence of MI, (2) raised cardiac enzyme (includ-
ing troponin), (3) hospital letter confirming MI. For
stroke, at least one of the following was required: (1)
report of ischaemic/haemorrhagic stroke on CT or MRI
scan, (2) hospital letter confirming stroke, (3) final
diagnosis from GP notes is ischaemic/haemorrhagic/
subarachnoid/other stroke (in absence of scan and let-
ter). For unstable angina a hospital letter confirming the
diagnosis was required.
Dates of CVD events were required for time-to-event
analysis. Exact dates were available for events ascer-
tained by record review or death certificates. In the case
of events only ascertained by self-report (n = 67, 13% of
all events), only a year was given; 31st December was
therefore used for the purposes of analysis (those with
missing year are excluded (n = 47 where no other inci-
dent event occurred)). For prevalent events, the date of
the earliest pre-baseline event was used for analysis.
Similarly for incident events, the date of the earliest
post-baseline event was used.
Risk factors
In addition to age, data on a variety of known and
potential risk factors for CVD were collected at baseline.
Smoking status (current, ex or never smoker), family
history of CVD (father, mother, brother or sister had a
heart attack or stroke), alcohol intake (never, socially, or
most days), limited fruit intake (both winter and sum-
mer fruit intake less than once a week/never), limited
physical activity (never take regular exercise), socioeco-
nomic position, and CVD medications (aspirin (British
National Formulary code [26] 02.09), statins and other
cholesterol-lowering drugs (code 02.12), beta-blockers
(code 02.04), ACE inhibitors (code 02.02.05), and blood-
pressure lowering drugs (codes 02.02.01, 02.02.08,
02.05.01-06, 02.06.02, 02.04)) were obtained through the
questionnaire. Life-course socioeconomic position (SEP)
was calculated as a score out of ten responses, with a
high score representing greater deprivation [27].
Responses given as “don’t know” to the individual com-
ponents of the score are treated as missing. However,
where the husband’s social class was missing or not
applicable, the responder’s own social class was used
where available (available for 392/816 (48%)).
Systolic blood pressure (SBP), waist circumference,
obesity (body mass index >30 kg/m2) and leg length
were obtained through the nurse examination. The pre-
sence of diabetes at baseline was identified from self-
report (n = 31), record review (n = 19), both self-report
and record review (n = 182), fasting glucose higher than
7 mmol/l only (n = 184), or diabetic medicines only (n
= 1)). Blood samples were taken after a minimum eight
hour fast and were used to obtain fasting glucose, total
cholesterol, HDLc and triglycerides [11]. Low density
lipoprotein cholesterol (LDLc) was calculated from total
cholesterol, HDLc and triglycerides using Friedwald’s
equation [28]. The Carstairs index [29] of area depriva-
tion (derived from the 1991 census, using data for Great
Britain) was calculated using postcodes at baseline [30].
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The 23 towns in the BWHHS were separated into four
geographical regions used previously [11]: Scotland
(comprising Ayr, Dumfermline, Falkirk), North England
(comprising Burnley, Carlisle, Darlington, Grimsby, Har-
rogate, Hartlepool, Scunthorpe, Southport, Wigan), Mid-
lands/Wales (comprising Mansfield, Merthyr Tydfil,
Newcastle Under Lyme, Shrewsbury), and South Eng-
land (comprising Bedford, Bristol, Exeter, Gloucester,
Guildford, Ipswich, Lowestoft).
Statistical methods
Regional differences in both fatal and non-fatal CVD
incidence were analysed using Cox regression adjusted
for age. Individuals were censored on the date of emi-
gration, date of death, or 30th September 2007. Loss to
follow-up for non-fatal incident CVD following non-
response to questionnaires (1091/3776 (29%) of those
alive at seven-year follow-up) or non-return of record
review (313/3730 (8%) of those alive at final record
Figure 1 Flow chart showing response to questionnaires and 7-year record review.
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review) is not considered here. However, loss of infor-
mation regarding non-fatal events is expected to be low
since loss to follow-up for both sources is small (n =
180, 5% of those alive at seven-year follow-up).
Further adjustment was made for known and potential
risk factors (see Table 1, section A). Corresponding
Kaplan-Meier survival functions were also produced for
both incident CVD and prevalent/incident CVD
combined.
The impact of missing values in covariates was investi-
gated using multiple imputed datasets, generated using
chained equations (with 10 cycles of regression switch-
ing). Ten datasets were imputed using all other factors
(including age and region) to impute missing values.
Log survival time and binary indicator for event were
also included as predictors [31]. Linear regression was
used to impute missing values for continuous variables
(SBP, LDLc, waist circumference, leg length, Carstairs
index, age at baseline), multinomial logistic regression
for categorical variables (alcohol intake, smoking status,
region), and logistic regression for binary variables (dia-
betes, obesity, family history, limited physical activity,
limited fruit intake, CVD medication, life-course socioe-
conomic position components). For the life-course
socioeconomic position measure, imputations were
made for the ten components separately. Clustering by
town is accounted for in all analyses through the use of
robust standard errors.
Results
The characteristics of 4286 baseline responders are
given in Table 1 by region. Missing data for the majority
of factors was <10%. However, missingness for data col-
lected at clinical examination varied by region, with the
Midlands/Wales having a greater proportion of missing
values for these factors. Socioeconomic position exhib-
ited more missing values than other variables since it
was derived from ten other variables.
In total there were 549 deaths in baseline responders
(12.8%) in the follow-up period. Of these, 150 were in
South England (11.4% of baseline responders), 117 in
Midlands/Wales (15.2%), 210 in North England (12.7%)
and 72 in Scotland (13.2%). CVD prevalence at baseline
and incidence over the seven year follow-up period for
the 4826 responders at baseline is given in Table 2 by
region. As reported previously, baseline prevalence of
CVD was highest in Scotland, and lowest in South
England.
Results of analysis for all incident events (with or
without prevalent disease) are given in Table 3. The
estimates based on the observed data for all events
combined suggest that compared to South England,
incidence is lower in all other regions, although these
estimates are imprecise; HR (after adjustment for risk
factors) for Midlands/Wales 0.66 (95% CI 0.43 to 1.00),
for North England 0.87 (95% CI 0.64 to 1.19) and for
Scotland 0.75 (95% CI 0.47 to 1.19)). As has already
been noted, Midlands/Wales exhibited a larger propor-
tion of missing responses at baseline for the covariates
of interest. Analysis of the imputed datasets suggests
that accounting for the missing data explained much
of the difference seen between each of the regions and
South England, although the point estimate for the
Midlands/Wales still suggests lower CVD incidence
compared to South England (HR 0.85 (95% CI 0.64 to
1.12)).
Analyses carried out separately for fatal and non-fatal
incident CVD provides further insight into the nature of
regional variations. The incidence of fatal CVD events
only was, after adjusting for all considered covariates
and missing data, higher in all the regions compared to
South England: Midlands/Wales HR 1.13 (95% 0.72 to
1.77), North England HR 1.19 (95% CI 0.82 to 1.74),
Scotland HR 1.09 (95% CI 0.66 to 1.82). In contrast,
incidence of non-fatal events was lower in the Midland/
Wales (HR 0.82 (95% CI 0.58 to 1.15) and Scotland (HR
0.86 (95% CI 0.58 to 1.28) compared to South England
(adjusting for covariates and missing data).
The Kaplan-Meier survival functions by region for
CVD incidence are shown in Figure 2. A similar figure
showing prevalent and incident events combined is pre-
sented in Figure 3. This illustrates that although there
are regional differences in CVD early in adult life [11],
as supported by analysis of CVD prevalence at baseline
in the BWHHS [11], there is little further divergence in
later life. This helps explain why an analysis of CVD
incidence occurring after age 69 (the mean age at base-
line in the BWHHS) does not demonstrate strong regio-
nal differences.
Discussion
Evidence from the BWHHS published previously indi-
cated that region was associated with CVD prevalence
over and above variation explained by known risk fac-
tors, with South England having the lowest prevalence
[11]. Results here based on seven-year follow-up data
suggest that regional variation in CVD incidence beyond
baseline (i.e. beyond the mean age of 69) exhibits a very
different pattern to that seen for CVD prevalence in this
population. For CVD incidence, much of the difference
between regions was explained by imputing missing cov-
ariate values, with hazard ratios for the Midlands/Wales,
North England and Scotland generally attenuated
towards no difference in incidence compared to south
England. However, Kaplan-Meier survival functions
showing prevalence and incidence combined suggest
that regional differences begin at around age 55, and are
prominent by age 69, when the baseline study was
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Table 1 Baseline characteristics by region
South England Midlands/
Wales
North England Scotland p-value^^
Number of towns 7 4 9 3
Contacted 2216 1199 2873 1008
Responders at baseline
(% of invited)
1319 (60%) 770 (64%) 1650 (57%) 547 (54%) < 0.0005
Responders in 2003
(% baseline responders§)
1141 (87%) 633 (82%) 1439 (87%) 464 (85%) 0.09
Responders in 2007
(% baseline responders§)
846 (72%) 450 (68%) 1037 (71%) 352 (74%) 0.2
Classical and potential risk factors for CVD (baseline)
Age (mean (SD)) 69.3 (5.5) 69.5 (5.6) 69.6 (5.5) 68.9 (5.3) 0.06
Smoking status < 0.0005
Never 817 (62%) 418 (54%) 864 (52%) 272 (50%)
Ex 389 (30%) 244 (32%) 584 (36%) 184 (34%)
Current 108 (8%) 101 (13%) 195 (12%) 91 (17%)
Missing 5 (0.4%) 7 (0.9%) 7 (0.4%) 0 (0%)
Diabetes 0.07
Yes (SR/RR) 67 (5.1%) 49 (6.4%) 86 (5.2%)^ 31 (5.6%)
Yes (fasting glucose only) 43 (3.3%) 31 (4.0%) 74 (4.5%) 36 (6.6%)
No 1209 (92%) 690 (90%) 1490 (90%) 480 (88%)
Systolic BP (sitting, mm/Hg)* 153.2 (23.9) 155.4 (23.9) 154.6 (24.0) 153.3 (25.4) 0.20
Missing 114 (9%) 150 (20%) 141 (9%) 16 (3%)
LDL cholesterol (mmol/l) 4.2 (1.1) 4.2 (1.1) 4.1 (1.1) 4.1 (1.1) 0.21
Missing 155 (12%) 186 (24%) 161 (10%) 22 (4%)
Waist circumference (mm)* 861.0 (119.3) 868.0 (120.7) 861.9 (122.9) 860.1 (125.8) 0.63
Missing 84 (6%) 126 (18%) 123 (8%) 3 (1%)
Obesity 0.29
Yes 430 (33%) 341 (44%) 565 (34%) 163 (30%)
No 813 (62%) 296 (39%) 967 (59%) 382 (70%)
Missing 76 (6%) 133 (17%) 118 (7%) 2 (< 1%)
Leg length (mm) 763.5 (41.4) 753.4 (42.9) 756.1 (40.2) 752.2 (39.5) < 0.0005
Missing 75 (6%) 133 (2%) 118 (7%) 2 (< 1%)
Family history of CVD** 750 (57%) 431 (56%) 893 (54%) 300 (55%) 0.49
Alcohol intake < 0.0005
Most days 253 (19%) 127 (17%) 276 (17%) 58 (11%)
Socially$ 819 (62%) 439 (57%) 970 (59%) 319 (58%)
Never 166 (13%) 133 (17%) 239 (15%) 109 (20%)
Missing 81 (6%) 71 (9%) 165 (10%) 61 (11%)
Physically inactive$ 739 (56%) 510 (66%) 935 (57%) 285 (52%) < 0.0005
Missing 149 (11%) 90 (9%) 214 (13%) 97 (18%)
Limited fruit/veg intake$$ 33 (2%) 44 (4%) 93 (3%) 40 (4%) < 0.0005
Missing 129 (10%) 83 (11%) 242 (15%) 90 (17%)
Carstairs index based on GB population data (mean (SD)) -0.9 (2.4) 0.6 (2.7) 0.5 (3.3) 2.67 (3.4) < 0.0005
Missing 24 (2%) 1 (< 1%) 8 (1%) 36 (7%)
Life-course SEP
(median (25th, 75th centiles))
4 (2, 5) 4 (3, 6) 4 (2, 6) 5 (3, 6) < 0.0005
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conducted. However, in the subsequent period between
baseline and seven-year follow-up, there is no further
divergence by region, although the differences by region
remain at age 76 (corresponding to the mean age at
seven-year follow-up). These results suggest that the
regional differences in CVD occur at earlier ages; while
examination of CVD prevalence is likely to show regio-
nal variation across a range of ages, regional differences
in CVD incidence may only be apparent at younger
ages. This possibility is supported by the original analy-
sis of the regional differences in incidence data among
men at much younger ages (40-59), which showed
marked north-south variation [18].
Explanation of findings
The absence of continued divergence of the regions in
terms of CVD may arise for a number of reasons. There
may be regional differences in terms of early diagnosis
or treatment of conditions such as angina, which may
arise due to differences in health care provision or
access to/use of health care services. Such differences in
diagnosis would influence the cohort at earlier ages, but
Table 1 Baseline characteristics by region (Continued)
Missing£ 305 (23%) 181 (24%) 452 (27%) 162 (30%)
CVD medication 487 (37%) 252 (33%) 673 (41%) 262 (48%) < 0.0005
Non-missing for all covariates 700 (53%) 382 (50%) 881 (53%) 293 (54%) 0.3
Note: Figures given in parentheses are percentages of the baseline responders unless otherwise stated
§ Alive at time of mailing
* Mean of measurements
** Sibling or parent had stroke or heart attack (self-report)
$ Those answering weekends only/once or twice a month/special occasions
$ Response to nurse-led examination question (not questionnaire)
$$ Missing where either summer fruit intake or winter fruit intake response is missing.
£ Missing at least one of the ten components of SEP. Missingness of individual components ranged from 2.5-14.4%.
^ Includes one individual with diabetes indicated by diabetic medicines only
^^ From chi-squared test for binary variables, linear regression for continuous variables, and ordered logistic regression for ordinal variables (life-course SEP).
Analyses carried out on non-missing values only. Analysis of diabetes variable combined all “yes” categories.
Table 2 CVD prevalence and incidence risk percent by region
South England Midlands/
Wales
North England Scotland
Number of baseline responders 1319 770 1650 547
Prevalent CVD at baseline (% of baseline responders) 213 (16.1%) 177 (23.0%) 320 (19.4%) 135 (24.7%)
Incident CVD - non-fatal
If prevalent disease at baseline
(% those with prevalent disease)*
5 (2.4%) 7 (4.0%) 16 (5.0%) 4 (3.0%)
If no prevalent disease at baseline
(% those without prevalent disease)
102 (9.2%) 47 (7.9%) 114 (8.6%) 38 (9.2%)
Total non-fatal events 107 (8.1%) 54 (7.0%) 130 (7.9%) 42 (7.7%)
Incident CVD - fatal
If prevalent disease at baseline
(% those with prevalent disease)
14 (6.6%) 16 (9.0%) 40 (12.5%) 10 (7.4%)
If no prevalent disease at baseline
(% those without prevalent disease)
32 (2.9%) 21 (3.5%) 40 (3.0%) 17 (4.1%)
Total fatal events 46 (3.5%) 37 (4.8%) 80 (4.8%) 27 (4.9%)
Incident CVD - fatal/non-fatal combined**
If prevalent disease at baseline
(% those with prevalent disease)
19 (8.9%) 21 (11.9%) 55 (17.1%) 14 (10.4%)
If no prevalent disease at baseline
(% those without prevalent disease)
129 (11.7%) 62 (10.5%) 148 (11.1%) 54 (13.1%)
Total incident events 148 (11.2%) 83 (10.8%) 203 (12.3%) 68 (12.4%)
* Only applies to MI and stroke events (angina and unstable angina cannot be both prevalent and incident).
** Fatal and non-fatal events may sum to greater than the combined events since some individuals have both fatal and non-fatal CVD events (but the combined
numbers only include the first of these, i.e. only include the non-fatal event)
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may have relatively little impact later on. If this were the
case, regions exhibiting higher CVD at younger ages
may actually represent better clinical practice (resulting
in earlier diagnosis and improved survival following a
CVD event). However, since these results are adjusted
for CVD medication, it seems unlikely that differences
in early detection account for regional differences in
CVD incidence. The potential impact of improved
healthcare on survival following a CVD event implies
that regions with higher non-fatal CVD incidence also
show lower fatal CVD incidence (as observed here in
South England).
Survivorship may also play a role. Although prevalent
non-fatal CVD events are included in analysis, fatal
CVD events (and other cause mortality) occurring prior
to baseline are not, since by definition an individual
must be alive to participate in the study. Those still
alive at the start of the study will thus be a healthier
group. The impact of this survivorship may vary
between regions since mortality (CVD and other causes)
may differ between regions prior to baseline. This would
imply that regions exhibiting lower CVD prevalence in
fact represent a group from which more of the least
healthy individuals have already died.
It may also be possible that a different type of individual
is at risk of early CVD (for example, before age 60). If this
early onset CVD differed by region, but later onset CVD
was more similar between regions, this would be consis-
tent with the observations described here. Lastly, it is pos-
sible that there are regional differences in response to
recent guidance on the management of cardiovascular risk
factors and both primary and secondary prevention.
Table 3 Hazard ratios for region comparisons in Cox regression models of CVD incidence and fatalities
N South England Midlands/
Wales
North
England
Scotland
Hazard ratios for incident non-fatal CVD events (95% CI)
Using subset with no missing values for any considered factor
Model 1 2253* 1 0.79 (0.50, 1.26) 0.97 (0.69, 1.37) 0.70 (0.41, 1.19)
Model 2** 2253* 1 0.71 (0.44, 1.14) 0.87 (0.61, 1.25) 0.62 (0.35, 1.12)
Using imputed data for missing values (10 imputations)
Model 1 4281*$ 1 0.64 (0.63, 1.23) 1.06 (0.82, 1.36) 0.92 (0.64, 1.33)
Model 2 4281*$ 1 0.82 (0.58, 1.15) 0.99 (0.76, 1.29) 0.86 (0.58, 1.28)
Hazard ratios for incident fatal CVD events (95% CI)
Using subset with no missing values for any considered factor
Model 1 2256 1 0.83 (0.38, 1.83) 1.19 (0.67, 2.10) 1.59 (0.78, 3.25)
Model 2 2256 1 0.63 (0.28, 1.41) 0.98 (0.54, 1.76) 1.07 (0.48, 2.37)
Using imputed data for missing values (10 imputations)
Model 1 4284$ 1 1.41 (0.91, 2.18) 1.53 (1.06, 2.20) 1.63 (1.01, 2.63)
Model 2 4284$ 1 1.13 (0.72, 1.77) 1.19 (0.82, 1.74) 1.09 (0.66, 1.82)
Hazard ratios for combined incident fatal/non-fatal CVD events (95% CI)
Using subset with no missing values for any considered factor
Model 1 2253* 1 0.77 (0.51, 1.16) 1.01 (0.75, 1.36) 0.92 (0.60, 1.41)
Model 2** 2253* 1 0.66 (0.43, 1.00) 0.87 (0.64, 1.19) 0.75 (0.47, 1.19)
Using imputed data for missing values (10 imputations)
Model 1 4281*$ 1 0.98 (0.75, 1.28) 1.20 (0.97, 1.48) 1.14 (0.85, 1.53)
Model 2 4281*$ 1 0.85 (0.64, 1.12) 1.05 (0.84, 1.31) 0.93 (0.68, 1.27)
* excludes 3 with event on date of baseline questionnaire
$ excludes 1 with missing date of birth and 1 with missing date for baseline questionnaire
** some evidence for violation of proportional hazards (global test in non-fatal Model 2a, p = 0.04; in combined Model 2a, p = 0.03)
Model 1: unadjusted
Model 2: adjusted for risk factors as described in Table 1 (except diabetes, where all cases were merged to give a binary variable)
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Consistency with other studies of geographic variation
Regional differences in cardiovascular disease incidence
and mortality have been reported for a number of other
countries, including the United Kingdom [32], the
United States [19,33], Canada [14], Finland [20], Sweden
[10], France [13,16], and across Europe [15]. Some of
these studies have sought to simply identify and describe
regional differences. Others have attempted to use
Figure 2 Unadjusted Kaplan-Meier survival function for incident CVD events (whole cohort, irrespective of baseline CVD prevalence).
All observed data (n = 4281).
Figure 3 Unadjusted Kaplan-Meier survival function for all CVD events (prevalent and incident combined). First line shows mean age at
baseline; second line shows mean age at seven-year follow-up. All observed data (n = 4285).
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known risk factors to explain the regional variations in
CVD [19,33], although in some cases analysis was per-
formed on aggregated data (i.e. individual patient data
were not available) [14]. A study of regional differences
in 12-year stroke incidence in the United States [33]
showed that the differences could largely, but not
entirely, be explained by known risk factors in a cohort
of 7000 men and women aged 45-74. More prominent
regional differences remained after adjustment in the
women. This supports the results from the BWHHS
cohort, which suggest that known risk factors do not
account for all observed geographical variation in CVD.
A further study in the United States has reported regio-
nal differences in stroke and fatal CVD, but not MI or
non-fatal/fatal CVD combined [19]. Adjustment for
known risk factors in this study further exaggerated
regional differences. However, restriction of participants
to physicians and exclusion of 16% of subjects with
missing baseline data raises questions regarding the gen-
eralisability of these results. Finally, the BRHS has pro-
vided much of the UK evidence for regional variations
in CVD in men. This work has provided evidence that
for men aged 40-59 at baseline, around 75% of the
between-town variation in 5-, 10-, and 15-year incidence
of coronary heart disease can be explained by smoking,
systolic blood pressure, exercise, social class, and height
[18]. This again suggests that most - but not all -
observed regional variations can be explained by classi-
cal risk factors.
Limitations and strengths of the study
One of the potential weaknesses of this analysis is miss-
ing data. This problem has two components, since there
are missing data in the CVD risk factors included as
covariates in the Cox models, and also non-response at
each of the three follow-up time-points. The former is
addressed through the use of multiple imputation,
which assumes that the missing covariate values are
missing at random (MAR) - that the missing values
depend on observed values of other variables, but not
on the missing values themselves. Given the well-docu-
mented strong relationships between many of the cov-
ariates of interest here, this would seem a generally
reasonable assumption. Furthermore, imputation based
on non-missing covariates is reasonable since individuals
do not generally have many missing covariates (of those
with at least one missing value at baseline, 1839/1976
(93%) have at least 9/15 non-missing values). The results
from analysis of the multiply imputed datasets suggest
that accounting for the missing data explains some of
the observed differences between regions.
The second component of the missing data issue is
non-response to either the baseline or follow-up ques-
tionnaires. Non-response to the follow-up questionnaires
is not addressed here, since it is anticipated that the
majority of self-report CVD events missed as a result of
this non-response would be picked up by record review
(only 5% of individuals are lost to follow-up from both
sources). Furthermore, there is little evidence of a differ-
ence in response by region at either three-year (c2 p =
0.09) or seven-year follow-up (c2 p = 0.18). Non-response
at baseline however is more pronounced than at subse-
quent waves (59% response across all regions) and there
is strong evidence for a difference in response at baseline
by region (c2 p < 0.0005). Since non-responders at base-
line are excluded from all analyses, this has implications
for bias and generalisability of the results presented here.
If regions with higher non-response at baseline actually
have higher CVD incidence, the large number of non-
responders (those at likely to be at highest risk of CVD)
would render estimates of regional differences
conservative.
Conclusions
To conclude, the British Women’s Heart and Health
Study provides a strong platform for regional analysis,
with randomly selected subjects from 23 towns repre-
senting areas throughout the UK. Furthermore, the
study includes over 4000 women with a mean of seven
years follow-up. These results show that in women,
regional differences in CVD (over and above those
explained by known risk factors) occur relatively early in
life, but do not continue to diverge in later life. Analysis
of the incidence of fatal and non-fatal CVD combined
showed different patterns of variation between the
regions, suggesting regional differences in prognosis fol-
lowing a CVD event. These findings imply that in
women, efforts to characterise and standardise regional
differences in CVD-related healthcare should be targeted
at those under 70. Further follow-up of the BWHHS is
required in order to increase numbers of events and
thus increase the precision of the estimates obtained in
these analyses. Further work is also needed to investi-
gate potential explanations for the apparent improve-
ment in CVD outcomes observed in South England
compared to other regions.
Additional material
Additional file 1: Baseline questionnaire. A self administered
questionnaire about lifestyle and medical history used at the baseline
visit.
Additional file 2: 3-year follow-up questionnaire (long form). A self
administered questionnaire about lifestyle and medical history which was
sent out in March 2003.
Additional file 3: 3-year follow-up questionnaire (short form). A self
administered questionnaire about lifestyle and medical history which was
sent out in March 2003.
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Additional file 4: 7-year follow-up questionnaire. A third self-
administered postal questionnaire was sent in 2007. This was about
health and lifestyle to see what was changed, and what has stayed the
same since the last survey in 2003.
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